Promega Corporation

Promega Corporation, doing business as Promega Corp, a for-profit life sciences manufacturer headquartered in Fitchburg, Wisconsin, supplies DNA extraction systems, molecular diagnostic reagents, forensic analysis equipment, luminescence and fluorescence assays, and customized laboratory consumables to federal agencies as a large-business prime contractor with no SBA certifications. The company competes entirely full-and-open, with 100% of its 1,933 recent awards (prime contracts and IDVs) carrying no set-aside designation. Promega holds named subsidiaries Turner Biosystems, Inc. and Terso Solutions, Inc. and operates from multiple locations including Madison, Wisconsin headquarters and facilities in Bethesda, Maryland and Durham, North Carolina.

Promega's federal customer base centers on defense healthcare, forensic, and civilian biomedical research missions. The top five customers by combined potential value account for 74% of dollars: the Department of the Army Medical Command (69 awards, $27.6 million combined potential value), the Defense Health Agency (25 awards, $17.3 million), the NIH Office of Logistics and Acquisition Operations (8 awards, $10.1 million), the FBI Headquarters Division (38 awards, $9.9 million), and the FDA (26 awards, $2.1 million). Across 82 distinct customer agencies served, activity volume has declined slightly year over year—26 awards in 2022 down to 13 in 2026—with combined potential value of $90.8 million and obligated dollars reaching $37 million (41% of potential value).

Promega's capability portfolio divides into three core product streams grounded in NAICS concentration. Biological product manufacturing (217 awards) anchors DNA extraction systems such as the Maxwell RSC 48 automated nucleic acid extraction platform, supplied to the CDC, NOAA, FDA, Veterans Affairs, and USDA Plant Protection and Quarantine for environmental sampling and high-throughput nucleic acid isolation. Analytical laboratory instrument manufacturing (156 awards) covers luminescence and fluorescence readers such as the GloMax Explorer and GloMax Discover multimode microplate readers, issued to NIH institutes including NIAID, NCATS, and NCI for cell viability, cytotoxicity, kinase activity, and viral assay applications. In-vitro diagnostic substance manufacturing (140 awards) encompasses assay kits and cell lines—CellTiter-Glo cell viability assays, LDH-Glo cytotoxicity assays, P450-Glo CYP screening systems, HIBIT-tagged cell lines, and RNasin Plus RNase inhibitor—supplied to NCATS, the National Institute on Drug Abuse, and NIDA for drug discovery, toxicology research, and mRNA vaccine development. Forensic DNA systems including PowerPlex Fusion and CE1024 Spectrum capillary electrophoresis instruments flow predominantly to the FBI Headquarters Division; a September 2025 sole-source award for three CE1024 systems with 24-capillary capability and three-year service agreement valued $838,317.60. A recent $294,894.60 sole-source award from the NIH Clinical Center procures GenePrint 24 System short tandem repeat (STR) amplification kits for engraftment monitoring in bone marrow and stem cell transplant patients, reflecting Promega's position as the sole manufacturer of these proprietary systems.

Vehicle concentration reflects Promega's entrenched position on legacy NIH and Army medical indefinite delivery vehicles. The company holds a $10 million NIH Office of Logistics and Acquisition Operations Blanket Purchase Agreement (award date December 31, 2023, completion date December 31, 2026) covering biological materials, chemicals, medical and scientific equipment, instruments, and maintenance repair services; task orders under this vehicle total approximately $65,406.50 across NCATS, NCI, and other institutes. A $938,761.50 single-award FDA BPA established September 8, 2026, for Maxwell RSC 48 DNA extraction systems or equal, including delivery, installation, and training, already carries a $434,961.80 BPA call award from September 10, 2026. The Defense Health Agency established a $2.9 million Blanket Purchase Agreement on September 25, 2025, for customized reagents and consumables, with a $165,606.46 call awarded January 27, 2026. An Army Medical Command indefinite delivery vehicle (W81XWH07D0003) generated 27 task orders valued at $3.2 million combined potential value. The FBI Headquarters Division awarded a $900,000 single-award indefinite delivery contract effective October 1, 2026, through September 30, 2031, for validation kits and consumables, with a $234,000 delivery order issued immediately. Recent Army Medical Command awards include $27.6 million combined potential value across 69 orders, substantially anchoring Promega's overall customer concentration.

Promega's subcontract footprint is minimal; seven sub-awards across the entire source portfolio. Notable sub-recipients include a July 2025 sub under Battelle National Biodefense Institute's National Biodefense Analysis and Countermeasures Center (NBACC) FFRDC contract for multiple reagents supporting the Department of Homeland Security, and a November 2024 sub under MriGlobal for a Maxwell RSC System procurement supporting the Mycobacterium tuberculosis quality assessment program. Grant sub-awards center on the Attorney General of Ohio, which has subcontracted Promega for Maxwell 48 extraction and MaxPrep liquid handler equipment and service, casework supplies, and lab accessories under DNA capacity-enhancement grant programs, with four sub-awards ranging from April 2024 to May 2025.

Activity trajectory shows steady but modest decline. Awards per year fell from 26 in 2022 to 13 in 2026 (year-to-date), while combined potential value remains robust at $90.8 million across the portfolio. Nine awards face ultimate completion in the next twenty-four months with combined potential value of $1 million, presenting modest recompete exposure relative to Promega's overall base. The company's multi-decade federal footprint (first award in source data June 15, 1990) and position on flagship NIH, Army Medical Command, FBI, and FDA vehicles position it as an established supplier of specialized life sciences instrumentation and consumables across civilian research, military healthcare, law enforcement forensic analysis, and public health missions.